Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 409

Results For "NDA"

4234 News Found

Research demonstrates Hoth Therapeutics HT-KIT for mast cell cancers reduces size and spread
Drug Approval | August 12, 2021

Research demonstrates Hoth Therapeutics HT-KIT for mast cell cancers reduces size and spread

Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasm


GW Pharmaceuticals receives approval for Epidyolex to treat seizures
Drug Approval | August 11, 2021

GW Pharmaceuticals receives approval for Epidyolex to treat seizures

TSC causes epilepsy in up to 85 % of patients, and up to 60 % of those patients do not respond to standard anti-seizure medicines


QIAGEN and GT Molecular collaborate to detect SARS-CoV-2 in wastewater
Drug Approval | August 11, 2021

QIAGEN and GT Molecular collaborate to detect SARS-CoV-2 in wastewater

Wastewater surveillance is becoming increasingly critical for community health monitoring for detecting COVID-19 outbreaks and the spread of other infectious diseases


New CAP guideline improves diagnoses of patients with Monoclonal Gammopathies
Healthcare | August 11, 2021

New CAP guideline improves diagnoses of patients with Monoclonal Gammopathies

The American Association for Clinical Chemistry (AACC); the American Society for Clinical Pathology (ASCP); the American Society of Hematology (ASH); and the International Myeloma Working Group (IMWG), collaborate to develop the guideline


FUJIFILM Irvine Scientific appointed global distributor of Presagen’s Life Whisperer
Digitisation | August 11, 2021

FUJIFILM Irvine Scientific appointed global distributor of Presagen’s Life Whisperer

High-resolution image-based ART workflow software uses artificial intelligence to provide objective embryo grading, to assist embryologists during embryo selection


Moderna to set up mRNA manufacturing in Canada
Biotech | August 11, 2021

Moderna to set up mRNA manufacturing in Canada

The collaboration will support Canada with direct access to rapid pandemic response capabilities


Pear Therapeutics’ three FDA authorised prescriptions available at OptumRx
Digitisation | August 11, 2021

Pear Therapeutics’ three FDA authorised prescriptions available at OptumRx

OptumRx to make Pear’s three commercial Prescription Digital Therapeutics accessible to patients with Optum formulary access.


Tesis Labs and Personal Genome Diagnostics tie-up to advance cancer treatment
Digitisation | August 11, 2021

Tesis Labs and Personal Genome Diagnostics tie-up to advance cancer treatment

The aim is to create new genomics solutions that could combat cancer and advance market access


Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China
Biotech | August 11, 2021

Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China

The approval is based on a multi-centre, single-arm, open-label pivotal clinical trial


Lupin posts net profit of Rs 542.46 cr. in Q1FY22
News | August 11, 2021

Lupin posts net profit of Rs 542.46 cr. in Q1FY22

The profits were bolstered by the Boehringer Ingelheim MEK program income